½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1399728

È¿¼Ò ½ÃÀå ±Ô¸ð : Á¦Ç°º°, ¿ëµµº°, ¿¹Ãø(2023-2032³â)

Enzymes Market Size - By Product (Proteases, Lipases, Carbohydrases, Polymerases & Nucleases, Phytases, Catalyses), Application (Food & Beverage, Processed Food, Dairy, Bakery, Confectionary) & Forecast, 2023 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 1200 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ È¿¼Ò ½ÃÀåÀº ¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ Å« Áøº¸, Áö¼Ó°¡´ÉÇÑ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿äÀÇ Áõ°¡, ´Ù¾çÇÑ »ê¾÷¿¡¼­ ´Ù¾çÇÑ ¿ëµµ¿¡ ÀÇÇØ ÃËÁøµÇ¸ç, 2023-2032³â CAGR 6.8%·Î È®´ëÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.

Economist Intelligence Unit¿¡ µû¸£¸é Áö³­ 5³â°£ Áö¼Ó°¡´ÉÇÑ »óÇ°¿¡ ´ëÇÑ ¼¼°è ¿Â¶óÀÎ °Ë»öÀÌ 71% ±ÞÁõÇßÀ¸¸ç, McKinsey & Co.ÀÇ Á¶»ç¿¡ µû¸£¸é ÀÀ´äÀÚÀÇ 66%(¹Ð·¹´Ï¾ó ¼¼´ëÀÇ °æ¿ì 75%)°¡ ±¸¸Å °áÁ¤¿¡ ÀÖÀ¸¸ç, Áö¼Ó°¡´É¼ºÀ» ¿ì¼±¼øÀ§·Î »ï°í ÀÖ½À´Ï´Ù. ÀÀ´äÀÚÀÇ 66%(¹Ð·¹´Ï¾ó ¼¼´ëÀÇ 75%)°¡ ±¸¸Å °áÁ¤¿¡ ÀÖÀ¸¸ç, Áö¼Ó°¡´É¼ºÀ» ¿ì¼±½ÃÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

È¿¼Ò´Â º»ÁúÀûÀ¸·Î Áö¼Ó°¡´ÉÇÑ »ýü Ã˸ŷμ­ ±âÁ¸ È­ÇÐ °øÁ¤¿¡ ´ëÇÑ Áö¼Ó°¡´ÉÇÑ ´ë¾ÈÀ» ã´Â ¾÷°è¿¡¼­ Å« ÁÖ¸ñÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ģȯ°æÀûÀÌ°í ¿¡³ÊÁö È¿À²ÀûÀ̸ç ȯ°æ ģȭÀûÀÎ ¹ÝÀÀÀ» ÃËÁøÇÏ´Â È¿¼ÒÀÇ ´É·ÂÀº Áö¼Ó°¡´É¼º¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö´Â Ãß¼¼¿Í ¸Â¹°·Á ÀÖ½À´Ï´Ù. ¶ÇÇÑ ³ó¾÷ ¹× Á¦Á¶¾÷°ú °°Àº »ê¾÷¿¡¼­ È¿¼ÒÀÇ »ýÅÂÀû ¹ßÀÚ±¹À» ÁÙÀÏ ¼ö ÀÖ´Â ÀáÀç·ÂÀ» ÀνÄÇÏ°í ÀÖÀ¸¸ç, Á¦Ç° ¼ö¿ä°¡ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù.

¼¼°è È¿¼Ò ½ÃÀåÀº Á¦Ç°, ¾ÖÇø®ÄÉÀÌ¼Ç ¹× Áö¿ªº°·Î ºÐ·ùµË´Ï´Ù.

¸®ÆľÆÁ¦ Á¦Ç° ºÎ¹®Àº ÁöÁú ´ë»ç¿¡ ÇʼöÀûÀÎ ¿ªÇÒ°ú ´Ù¾çÇÑ ¿ëµµ·Î ÀÎÇØ 2032³â±îÁö Å« ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Çʼö È¿¼ÒÀÎ ¸®ÆľÆÁ¦´Â ½ÄÇ° »ê¾÷ÀÇ ´Ù¾çÇÑ °øÁ¤¿¡ ±â¿©ÇÏ¿© ¸À°ú Áú°¨À» Çâ»ó½Ãŵ´Ï´Ù. ¶ÇÇÑ ¹ÙÀÌ¿ÀµðÁ© »ý»ê°ú ÀǾàÇ°¿¡µµ »ç¿ëµÇ¾î ¹ü¿ë¼ºÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. Áö¼Ó°¡´ÉÇÑ °üÇà°ú ȯ°æ ģȭÀû ÀÎ ´ë¾È¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ȯ°æ ģȭÀû ÀÎ °øÁ¤À» ÃËÁøÇÏ´Â ¸®ÆľÆÁ¦ÀÇ Á߿伺ÀÌ ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù.

º£ÀÌÄ¿¸® ¿ëµµ´Â È¿¼Ò°¡ ¹ÝÁ×ÀÇ ¹ß´Þ¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ½Ä°¨À» °³¼±Çϸç ÀúÀå ±â°£À» ¿¬ÀåÇÏ´Â ´É·ÂÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß ²ÙÁØÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ŭ¸° ¶óº§ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â Çõ½ÅÀûÀÎ È¿¼Ò ¼Ö·ç¼ÇÀÇ °³¹ßÀ» ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ´Â ±¸¿î ½ÄÇ°ÀÇ Ç°Áú°ú ½Å¼±µµ¸¦ Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ´Ù¾çÇÑ ¼ÒºñÀÚ ¼±È£µµ¸¦ ÃæÁ·½Ãų ¼ö ÀÖ½À´Ï´Ù.

ºÏ¹ÌÀÇ È¿¼Ò »ê¾÷ ±Ô¸ð´Â ÀÌ Áö¿ªÀÇ È¿¼Ò ¼ö¿ä, »ý¸í°øÇÐÀÇ ¹ßÀü, ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷ÀÇ °­·ÂÇÑ Á¸Àç°¨, Áö¼Ó°¡´ÉÇÑ °üÇà¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó 2032³â±îÁö °­·ÂÇÑ ¼ºÀåÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. È¿¼Ò´Â ½ÄÇ° ¹× À½·á, ¹ÙÀÌ¿À¿¬·á »ý»ê, Á¦¾à µî ´Ù¾çÇÑ »ê¾÷¿¡¼­ ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ´Â °ü·Ã R&D È°µ¿°ú ÇÔ²² ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå È¿¼Ò »ê¾÷ ÀλçÀÌÆ®

  • »ê¾÷ ¼¼ºÐÈ­
  • ¾÷°è »óȲ(2018-2032³â)
  • ¿¡ÄڽýºÅÛ ºÐ¼®
    • À¯Åë ä³Î ºÐ¼®
    • ÀÌÀÍ·ü µ¿Çâ
    • º¥´õ ¸ÅÆ®¸¯½º
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ÃËÁø¿äÀÎ
      • µ¿¹° »ç·á »ê¾÷À¸·ÎºÎÅÍÀÇ ¼ö¿ä Áõ°¡
      • ¹ÙÀÌ¿À¿¬·á¿Í Á¾ÀÌ ÆÞÇÁ »ê¾÷¿¡¼­ ÀÀ¿ë¹üÀ§ÀÇ È®´ë
      • È¿¼Ò °øÇÐÀ¸·ÎÀÇ Ä§Åõ
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ©¡¤°úÁ¦
      • Ç¥ÁØÈ­µÈ ±ÔÁ¦ °¡À̵å¶óÀÎÀÇ °á¿©
  • ƯÁ¤ »ê¾÷¿¡ ÀÛ¿ëÇÏ´Â È¿¼Ò
  • È¿¼Ò ³óÃà°ú 1Â÷ Á¤Á¦
    • È¿¼ÒÀÇ ¼±ÅÃÀ» °áÁ¤ÇÏ´Â ¸î°³ÀÇ Áß¿äÇÑ Æ¯Â¡
    • È¿¼Ò ³óÃà°ú Á¤Á¦¿¡ »ç¿ëµÇ´Â ±â¼ú
  • 2022³âÀÇ ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ »óȲ
    • ¹Ì±¹
      • °¡À̵å¶óÀÎ
        • ID
        • È¿¼Ò Á¦Á¦ÀÇ Á¶¼º
        • Á¦Á¶ °øÁ¤
        • µ¿Àϼº°ú ¼øµµÀÇ »ç¾ç
      • CFR-¹Ì±¹¿¬¹æ±âÁØÁý Title 21-½ÄÇ°ÀǾ౹(FDA)
    • À¯·´
      • ±ÔÄ¢(EC) No 1331/2008(OJ L 354, p1, 31/12/2008)
      • À¯·´À§¿øȸ ±ÔÄ¢(EU) No 234/2011
      • EU¿¡¼­ ½Äǰ÷°¡Á¦À» ±ÔÁ¦ÇÏ´Â ±âŸ ¹ý·ü
    • Áß±¹
      • ½Äǰ÷°¡Á¦ »ç¿ë¿¡ °üÇÑ ±¹°¡ ½ÄÇ° ¾ÈÀü±âÁØ(GB2760-2014)
        • ºÎ·Ï A : ½Äǰ÷°¡Á¦ÀÇ »ç¿ë¿¡ °üÇÑ ±ÔÁ¤
        • ºÎ·Ï B : ½ÄÇ° Çâ·á ¹°ÁúÀÇ »ç¿ë¿¡ °üÇÑ ±ÔÁ¤
        • ºÎ¼Ó ¹®¼­ C : ½ÄÇ° °¡°øÁ¶Á¦ÀÇ »ç¿ë¿¡ °üÇÑ ±ÔÁ¤
        • ºÎ¼Ó¼­ D : ºÎ·Ï D : ÷°¡Á¦ÀÇ ±â´É
        • ºÎ·Ï E : ½ÄÇ° ºÐ·ù ½Ã½ºÅÛ
  • ±â¼ú°ú Çõ½Å Àü¸Á
    • °íü Ç¥¸é ¹ßÈ¿
    • ¼öÁß ¹è¾ç¹ý(CSTR)
  • °¡°Ý ºÐ¼®
    • Áö¿ªº° °¡°Ý°áÁ¤
  • ¿ø·á µ¿Çâ
  • PorterÀÇ »ê¾÷ ºÐ¼®
  • °æÀï ±¸µµ(2022³â)
    • ½ÃÀå Á¡À¯À² ºÐ¼®(2022³â)
    • ƯÇã¿Í ¶óÀ̼±½Ì
    • Àü·« ´ë½Ãº¸µå
    • ÁÖ¿ä ÀÌÇØ°ü°èÀÚ
    • È¿¼Ò »ý»ê °øÀå : ±¹°¡º°
    • È¿¼Ò ¿¬±¸°³¹ß ½Ã³ª¸®¿À
    • È¿¼Ò »ê¾÷¿¡¼­ ÁÖ¿ä µô·¯¿Í ¿¡ÀÌÀüÆ®ÀÇ ±¹°¡º° »ó¼¼
      • ºÏ¹Ì
        • ¹Ì±¹
        • ij³ª´Ù
      • À¯·´
        • µ¶ÀÏ
        • ¿µ±¹
        • ÇÁ¶û½º
        • ÀÌÅ»¸®¾Æ
        • ½º¿þµ§
        • ¿À½ºÆ®¸®¾Æ
        • Æú¶õµå
        • ·¯½Ã¾Æ
        • ½ºÆäÀÎ
      • ¾Æ½Ã¾ÆÅÂÆò¾ç
        • Áß±¹
        • Àεµ
        • ÀϺ»
        • Çѱ¹
        • Àεµ³×½Ã¾Æ
        • ű¹
        • ¸»·¹À̽þÆ
        • È£ÁÖ
      • ¶óƾ¾Æ¸Þ¸®Ä«
        • ºê¶óÁú
        • ¾Æ¸£ÇîƼ³ª
        • ¸ß½ÃÄÚ
      • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
        • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
        • ¾Æ¶ø¿¡¹Ì¸®Æ®
        • »ç¿ìµð¾Æ¶óºñ¾Æ
        • Äí¿þÀÌÆ®
        • ÀÌÁýÆ®
  • PESTEL ºÐ¼®
  • °¢ È¿¼Ò À¯Çü ó¹æ

Á¦4Àå È¿¼Ò ½ÃÀå : Á¦Ç°º°

  • ¼¼°èÀÇ È¿¼Ò ½ÃÀåÀÇ Á¦Ç°º° Á¡À¯À²(2018³â¡¤2032³â)
  • ÇÁ·ÎÅ×¾ÆÁ¦
  • ¸®ÆľÆÁ¦
  • ź¼öÈ­¹° ºÐÇØ È¿¼Ò
    • ¾Æ¹Ð¶ó¾ÆÁ¦
    • Å©½Ç¶ó³ª¾ÆÁ¦
    • ¼¿·ê¶ó¾ÆÁ¦
    • ÆåƼ³ª¾ÆÁ¦
    • ¶ôŸ¾ÆÁ¦
  • Æú¸®¸Þ¶ó¾ÆÁ¦ & ´ºÅ¬·¹¾ÆÁ¦
  • ÇÇŸ¾ÆÁ¦
  • Ä«Å»¶ó¾ÆÁ¦
  • ±âŸ

Á¦5Àå È¿¼Ò ½ÃÀå : Áö¿ªº°

  • ¼¼°èÀÇ È¿¼Ò ½ÃÀåÀÇ Áö¿ªº° Á¡À¯À²(2018³â¡¤2032³â)
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½º¿þµ§
    • ¿À½ºÆ®¸®¾Æ
    • Æú¶õµå
    • ·¯½Ã¾Æ
    • ½ºÆäÀÎ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • Àεµ³×½Ã¾Æ
    • ű¹
    • ¸»·¹À̽þÆ
    • È£ÁÖ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîƼ³ª
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • Äí¿þÀÌÆ®
    • ÀÌÁýÆ®

Á¦6Àå ±â¾÷ °³¿ä

  • BASF
  • Royal DSM
  • Chr. Hansen
  • Enmex
  • Advanced Enzymes
  • Danisco A/S
  • Specialty Enzymes and Probiotics
  • Aumgene Biosciences
  • Lumis Biotech
  • Codexis
  • Hayashibara
  • Enzyme Innovation
  • AB Enzymes
  • Novozymes
  • Amano Enzyme
  • Aum Enzymes
  • National Enzyme Company
  • Novus International
  • Lonza Group
  • Roche
  • Caprienzymes
  • Asahi Kasei Pharma Corporation
  • Enzymatic Deinking Technologies LLC
  • PAC Bio Fungbact
  • BioResource International
  • Direvo Biotech AG
KSA 24.01.05

The global enzymes market is expected to expand at a CAGR of 6.8% during 2023-2032, driven by major advancements in biotechnology, increased demand for sustainable solutions, and diverse application in various industries.

According to the Economist Intelligence Unit, in the last five years, global online searches for sustainable goods surged by 71% and a McKinsey & Co. survey revealed that 66% of respondents, with 75% of millennials, prioritize sustainability in their purchasing decisions, clearly expressing consumer preference.

Enzymes, as inherently sustainable biocatalysts, have garnered substantial attention across industries seeking alternatives to traditional chemical processes and sustainable solutions. Their ability to facilitate green, energy-efficient, and environmentally positive reactions aligns with the heightened emphasis on sustainability. Moreover, industries like agriculture and manufacturing, are recognizing the potential of enzymes to reduce the ecological footprint, boosting the product demand.

The global enzymes market is classified based on product, application, and region.

The lipases product segment is poised for significant growth through 2032, fuelled by its indispensable role in lipid metabolism and diverse applications. Lipases, essential enzymes, contribute to various processes spanning the food industry, enhancing both flavor and texture. They are also used in biodiesel production and pharmaceuticals, showcasing their versatility. The heightened demand for sustainable practices and green alternatives further amplify the significance of lipases, as they facilitate eco-friendly processes.

The bakery application segment is expected to witness steady growth during the forecast period owing to the ability of enzymes to influence dough development, improve texture, and extend shelf life. The growing demand for clean label products is pushing the development of innovative enzyme solutions. They not only cater to enhancing the quality and freshness of baked goods but meet the wider consumer preference.

North America enzymes industry size is anticipated to register robust growth through 2032 driven by the region's demand for enzymes, advancements in biotechnology, a strong presence of key players, and a growing awareness of sustainable practices. The enzymes have extensive applications in industries such as food & beverage, biofuel production, and pharmaceuticals. This, along with the related R&D activities further propel the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Methodology
    • 1.1.1 Initial data exploration
    • 1.1.2 Statistical model and forecast
    • 1.1.3 Industry insights and validation
    • 1.1.4 Definitions & assumptions
    • 1.1.5 Assumptions, scope & forecast parameters
  • 1.2 Data Sources
    • 1.2.1 Secondary
    • 1.2.2 Primary

Chapter 2 Executive Summary

  • 2.1 Enzymes industry 360 degree synopsis, 2018 - 2032
  • 2.2 Business trends
  • 2.3 Product trends
  • 2.4 Application trends
  • 2.5 Regional trends

Chapter 3 Enzymes Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018 - 2032
  • 3.3 Industry ecosystem analysis
    • 3.3.1 Distribution channel analysis
    • 3.3.2 Profit margin trends
    • 3.3.3 Vendor matrix
  • 3.4 Industry impact forces
    • 3.4.1 Growth drivers
      • 3.4.1.1 Rising demand from the animal feed industry
      • 3.4.1.2 Increasing application scope in biofuels and pulp & paper industry
      • 3.4.1.3 Penetration in enzyme engineering
    • 3.4.2 Industry pitfalls & challenges
      • 3.4.2.1 Lack of standardized regulatory guidelines
  • 3.5 Enzymes that work on specific industry
  • 3.6 Concentration and primary purification of enzymes
    • 3.6.1 Some of the essential features determining the choice of enzymes
    • 3.6.2 Techniques used in concentration and purification of enzymes
  • 3.7 Growth potential analysis, 2022
  • 3.8 Regulatory landscape
    • 3.8.1 U.S.
      • 3.8.1.1 Guidelines
        • 3.8.1.1.1 Identity
        • 3.8.1.1.2 Composition of the enzyme preparation
        • 3.8.1.1.3 Manufacturing Process
        • 3.8.1.1.4 Specifications for Identity and Purity
      • 3.8.1.2 CFR - Code of Federal Regulations Title 21 - Food and Drug Administration (FDA)
    • 3.8.2 Europe
      • 3.8.2.1 Regulation (EC) No 1331/2008 (OJ L 354, p1, 31/ 12/2008)
      • 3.8.2.2 Commission Regulation (EU) No 234/2011
      • 3.8.2.3 Other laws regulating food additives in the EU
    • 3.8.3 China
      • 3.8.3.1 National Food Safety Standard for Food Additive Use (GB2760-2014)
        • 3.8.3.1.1 Appendix A: Provisions for the Use of Food Additives
        • 3.8.3.1.2 Appendix B: Provisions for the Use of Food Flavoring Substances:
        • 3.8.3.1.3 Appendix C: Provisions for the Use of Food Processing Aids.
        • 3.8.3.1.4 Appendix D: Additives functions.
        • 3.8.3.1.5 Appendix E: Food category system.
  • 3.9 Technology & innovation landscape
    • 3.9.1 Solid surface fermentation
    • 3.9.2 Submerged Culture method (CSTR)
  • 3.10 Pricing analysis
    • 3.10.1 Regional pricing
  • 3.11 Raw material trends
  • 3.12 Porter's analysis
  • 3.13 Competitive landscape, 2022
    • 3.13.1 Market share analysis, 2022
    • 3.13.2 Patents & licensing
    • 3.13.3 Strategy dashboard
    • 3.13.4 Key stakeholders
    • 3.13.5 Enzyme production plants, by countries
    • 3.13.6 R&D scenario of enzymes
    • 3.13.7 Country wise details of key dealers and agents in enzymes industry
      • 3.13.7.1 North America
        • 3.13.7.1.1 U.S.
        • 3.13.7.1.2 Canada
      • 3.13.7.2 Europe
        • 3.13.7.2.1 Germany
        • 3.13.7.2.2 UK
        • 3.13.7.2.3 France
        • 3.13.7.2.4 Italy
        • 3.13.7.2.5 Sweden
        • 3.13.7.2.6 Austria
        • 3.13.7.2.7 Poland
        • 3.13.7.2.8 Russia
        • 3.13.7.2.9 Spain
      • 3.13.7.3 Asia Pacific
        • 3.13.7.3.1 China
        • 3.13.7.3.2 India
        • 3.13.7.3.3 Japan
        • 3.13.7.3.4 South Korea
        • 3.13.7.3.5 Indonesia
        • 3.13.7.3.6 Thailand
        • 3.13.7.3.7 Malaysia
        • 3.13.7.3.8 Australia
      • 3.13.7.4 Latin America
        • 3.13.7.4.1 Brazil
        • 3.13.7.4.2 Argentina
        • 3.13.7.4.3 Mexico
      • 3.13.7.5 MEA
        • 3.13.7.5.1 South Africa
        • 3.13.7.5.2 UAE
        • 3.13.7.5.3 Saudi Arabia
        • 3.13.7.5.4 Kuwait
        • 3.13.7.5.5 Egypt
  • 3.14 PESTEL analysis
  • 3.15 Formulation of each enzyme type

Chapter 4 Enzymes Market, By Product

  • 4.1 Global enzymes market share by product, 2018 & 2032
  • 4.2 Proteases
  • 4.3 Lipases
  • 4.4 Carbohydrases
    • 4.4.1 Amylases
    • 4.4.2 Xylanases
    • 4.4.3 Cellulases
    • 4.4.4 Pectinases
    • 4.4.5 Lactases
  • 4.5 Polymerases & nucleases
  • 4.6 Phytases
  • 4.7 Catalases
  • 4.8 Others

Chapter 5 Enzymes Market, By Region

  • 5.1 Global enzymes market share by region, 2018 & 2032
  • 5.2 North America
    • 5.2.1 Market estimates and forecast, 2018 - 2032, (Kilotons) (USD Million)
    • 5.2.2 Market estimates and forecast by product, 2018 - 2032, (Kilotons) (USD Million)
    • 5.2.3 Proteases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.2.4 Lipases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.2.5 Carbohydrases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.2.5.1 Amylases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.2.5.2 Xylanases/hemicellulase market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.2.5.3 Cellulase market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.2.5.4 Pectinase market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.2.5.5 Lactases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.2.6 Polymerases & nucleases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.2.7 Phytases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.2.8 Catalases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.2.9 Market estimates and forecast from other products, by application, 2018 - 2032, (Kilotons) (USD Million)

Similar information is provided for

    • 5.2.10 U.S.
    • 5.2.11 Canada
  • 5.3 Europe
    • 5.3.1 Market estimates and forecast, 2018 - 2032, (Kilotons) (USD Million)
    • 5.3.2 Market estimates and forecast by product, 2018 - 2032, (Kilotons) (USD Million)
    • 5.3.3 Proteases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.3.4 Lipases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.3.5 Carbohydrases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.3.5.1 Amylases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.3.5.2 Xylanases/hemicellulase market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.3.5.3 Cellulase market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.3.5.4 Pectinase market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.3.5.5 Lactases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.3.6 Polymerases & nucleases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.3.7 Phytases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.3.8 Catalases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.3.9 Market estimates and forecast from other products, by application, 2018 - 2032, (Kilotons) (USD Million)

Similar information is provided for

    • 5.3.10 Germany
    • 5.3.11 UK
    • 5.3.12 France
    • 5.3.13 Italy
    • 5.3.14 Sweden
    • 5.3.15 Austria
    • 5.3.16 Poland
    • 5.3.17 Russia
    • 5.3.18 Spain
  • 5.4 Asia Pacific
    • 5.4.1 Market estimates and forecast, 2018 - 2032, (Kilotons) (USD Million)
    • 5.4.2 Market estimates and forecast by product, 2018 - 2032, (Kilotons) (USD Million)
    • 5.4.3 Proteases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.4.4 Lipases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.4.5 Carbohydrases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.4.5.1 Amylases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.4.5.2 Xylanases/hemicellulase market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.4.5.3 Cellulase market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.4.5.4 Pectinase market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.4.5.5 Lactases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.4.6 Polymerases & nucleases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.4.7 Phytases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.4.8 Catalases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.4.9 Market estimates and forecast from other products, by application, 2018 - 2032, (Kilotons) (USD Million)

Similar information is provided for

    • 5.4.10 China
    • 5.4.11 India
    • 5.4.12 Japan
    • 5.4.13 South Korea
    • 5.4.14 Indonesia
    • 5.4.15 Thailand
    • 5.4.16 Malaysia
    • 5.4.17 Australia
  • 5.5 Latin America
    • 5.5.1 Market estimates and forecast, 2018 - 2032, (Kilotons) (USD Million)
    • 5.5.2 Market estimates and forecast by product, 2018 - 2032, (Kilotons) (USD Million)
    • 5.5.3 Proteases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.5.4 Lipases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.5.5 Carbohydrases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.5.5.1 Amylases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.5.5.2 Xylanases/hemicellulase market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.5.5.3 Cellulase market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.5.5.4 Pectinase market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.5.5.5 Lactases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.5.6 Polymerases & nucleases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.5.7 Phytases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.5.8 Catalases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.5.9 Market estimates and forecast from other products, by application, 2018 - 2032, (Kilotons) (USD Million)

Similar information is provided for

    • 5.5.10 Brazil
    • 5.5.11 Argentina
    • 5.5.12 Mexico
  • 5.6 MEA
    • 5.6.1 Market estimates and forecast, 2018 - 2032, (Kilotons) (USD Million)
    • 5.6.2 Market estimates and forecast by product, 2018 - 2032, (Kilotons) (USD Million)
    • 5.6.3 Proteases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.6.4 Lipases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.6.5 Carbohydrases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.6.5.1 Amylases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.6.5.2 Xylanases/hemicellulase market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.6.5.3 Cellulase market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.6.5.4 Pectinase market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
      • 5.6.5.5 Lactases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.6.6 Polymerases & nucleases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.6.7 Phytases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.6.8 Catalases market estimates and forecast by application, 2018 - 2032, (Kilotons) (USD Million)
    • 5.6.9 Market estimates and forecast from other products, by application, 2018 - 2032, (Kilotons) (USD Million)

Similar information is provided for

    • 5.6.10 South Africa
    • 5.6.11 UAE
    • 5.6.12 Saudi Arabia
    • 5.6.13 Kuwait
    • 5.6.14 Egypt

Chapter 6 Company Profiles

  • 6.1 BASF
    • 6.1.1 Business Overview
    • 6.1.2 Financial Data
    • 6.1.3 Product Landscape
    • 6.1.4 Strategic Outlook
    • 6.1.5 SWOT analysis
  • 6.2 Royal DSM
    • 6.2.1 Business Overview
    • 6.2.2 Financial Data
    • 6.2.3 Product Landscape
    • 6.2.4 Strategic Outlook
    • 6.2.5 SWOT analysis
  • 6.3 Chr. Hansen
    • 6.3.1 Business Overview
    • 6.3.2 Financial Data
    • 6.3.3 Product Landscape
    • 6.3.4 Strategic Outlook
    • 6.3.5 SWOT analysis
  • 6.4 Enmex
    • 6.4.1 Business Overview
    • 6.4.2 Financial Data
    • 6.4.3 Product Landscape
    • 6.4.4 SWOT analysis
  • 6.5 Advanced Enzymes
    • 6.5.1 Business Overview
    • 6.5.2 Financial Data
    • 6.5.3 Product Landscape
    • 6.5.4 Strategic Outlook
    • 6.5.5 SWOT analysis
  • 6.6 Danisco A/S
    • 6.6.1 Business Overview
    • 6.6.2 Financial Data
    • 6.6.3 Product Landscape
    • 6.6.4 Strategic Outlook
    • 6.6.5 SWOT analysis
  • 6.7 Specialty Enzymes and Probiotics
    • 6.7.1 Business Overview
    • 6.7.2 Financial Data
    • 6.7.3 Product Landscape
    • 6.7.4 Swot analysis
  • 6.8 Aumgene Biosciences
    • 6.8.1 Business Overview
    • 6.8.2 Financial Data
    • 6.8.3 Product Landscape
    • 6.8.4 Strategic Outlook
    • 6.8.5 SWOT analysis
  • 6.9 Lumis Biotech
    • 6.9.1 Business Overview
    • 6.9.2 Financial Data
    • 6.9.3 Product Landscape
    • 6.9.4 Strategic Outlook
    • 6.9.5 SWOT analysis
  • 6.10 Codexis
    • 6.10.1 Business Overview
    • 6.10.2 Financial Data
    • 6.10.3 Product Landscape
    • 6.10.4 Strategic Outlook
    • 6.10.5 SWOT analysis
  • 6.11 Hayashibara
    • 6.11.1 Business Overview
    • 6.11.2 Financial Data
    • 6.11.3 Product Landscape
    • 6.11.4 Strategic Outlook
    • 6.11.5 SWOT analysis
  • 6.12 Enzyme Innovation
    • 6.12.1 Business Overview
    • 6.12.2 Financial Data
    • 6.12.3 Product Landscape
    • 6.12.4 Strategic Outlook
    • 6.12.5 SWOT analysis
  • 6.13 AB Enzymes
    • 6.13.1 Business Overview
    • 6.13.2 Financial Data
    • 6.13.3 Product Landscape
    • 6.13.4 Strategic Outlook
    • 6.13.5 SWOT analysis
  • 6.14 Novozymes
    • 6.14.1 Business Overview
    • 6.14.2 Financial Data
    • 6.14.3 Product Landscape
    • 6.14.4 Strategic Outlook
    • 6.14.5 SWOT analysis
  • 6.15 Amano Enzyme
    • 6.15.1 Business Overview
    • 6.15.2 Financial Data
    • 6.15.3 Product Landscape
    • 6.15.4 Strategic Outlook
    • 6.15.5 SWOT analysis
  • 6.16 Aum Enzymes
    • 6.16.1 Business Overview
    • 6.16.2 Financial Data
    • 6.16.3 Product Landscape
    • 6.16.4 Strategic Outlook
    • 6.16.5 SWOT analysis
  • 6.17 National Enzyme Company
    • 6.17.1 Business Overview
    • 6.17.2 Financial Data
    • 6.17.3 Product Landscape
    • 6.17.4 Strategic Outlook
    • 6.17.5 SWOT analysis
  • 6.18 Novus International
    • 6.18.1 Business Overview
    • 6.18.2 Financial data
    • 6.18.3 Product Landscape
    • 6.18.4 Strategic Outlook
    • 6.18.5 SWOT analysis
  • 6.19 Lonza Group
    • 6.19.1 Business Overview
    • 6.19.2 Financial Data
    • 6.19.3 Product Landscape
    • 6.19.4 Strategic Outlook
    • 6.19.5 SWOT analysis
  • 6.20 Roche
    • 6.20.1 Business Overview
    • 6.20.2 Financial Data
    • 6.20.3 Product Landscape
    • 6.20.4 Strategic Outlook
    • 6.20.5 SWOT analysis
  • 6.21 Caprienzymes
    • 6.21.1 Business Overview
    • 6.21.2 Product Landscape
    • 6.21.3 Strategic Outlook
    • 6.21.4 SWOT analysis
  • 6.22 Asahi Kasei Pharma Corporation
    • 6.22.1 Business Overview
    • 6.22.2 Financial data
    • 6.22.3 Product Landscape
    • 6.22.4 Strategic Outlook
    • 6.22.5 SWOT analysis
  • 6.23 Enzymatic Deinking Technologies LLC
    • 6.23.1 Business Overview
    • 6.23.2 Financial data
    • 6.23.3 Product Landscape
    • 6.23.4 SWOT analysis
  • 6.24 PAC Bio Fungbact
    • 6.24.1 Business Overview
    • 6.24.2 Financial data
    • 6.24.3 Product Landscape
    • 6.24.4 SWOT analysis
  • 6.25 BioResource International
    • 6.25.1 Business Overview
    • 6.25.2 Financial data
    • 6.25.3 Product Landscape
    • 6.25.4 Strategic Outlook
    • 6.25.5 SWOT analysis
  • 6.26 Direvo Biotech AG
    • 6.26.1 Business Overview
    • 6.26.2 Financial data
    • 6.26.3 Product Landscape
    • 6.26.4 Strategic Outlook
    • 6.26.5 SWOT analysis
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦